𝔖 Scriptorium
✦   LIBER   ✦

πŸ“

Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals


Year
2010
Tongue
English
Leaves
950
Category
Library

⬇  Acquire This Volume

No coin nor oath required. For personal study only.

✦ Synopsis


A real-world guide to the production and manufacturing of biopharmaceuticals

While much has been written about the science of biopharmaceuticals, there is a need for practical, up-to-date information on key issues at all stages of developing and manufacturing commercially viable biopharmaceutical drug products. This book helps fill the gap in the field, examining all areas of biopharmaceuticals manufacturing, from development and formulation to production and packaging.

Written by a group of experts from industry and academia, the book focuses on real-world methods for maintaining product integrity throughout the commercialization process, clearly explaining the fundamentals and essential pathways for all development stages. Coverage includes:

  • Research and early development phase?appropriate approaches for ensuring product stability

  • Development of commercially viable formulations for liquid and lyophilized dosage forms

  • Optimal storage, packaging, and shipping methods

  • Case studies relating to therapeutic monoclonal antibodies, recombinant proteins, and plasma fractions

  • Useful analysis of successful and failed products

Formulation and Process Development Strategies for Manufacturing Biopharma-ceuticals is an essential resource for scientists and engineers in the pharmaceutical and biotech industries, for government and regulatory agencies, and for anyone with an interest in the latest developments in the field.Content:
Chapter 1 The Structure of Biological Therapeutics (pages 1–40): Sheryl Martin?Moe, Tim Osslund, Y. John Wang, Tahir Mahmood, Rohini Deshpande and Susan Hershenson
Chapter 2 Chemical Instability in Peptide and Protein Pharmaceuticals (pages 41–67): Elizabeth M. Topp, Lei Zhang, Hong Zhao, Robert W. Payne, Gabriel J. Evans and Mark Cornell Manning
Chapter 3 Physical Stability of Protein Pharmaceuticals (pages 69–104): Byeong S. Chang and Bernice Yeung
Chapter 4 Immunogenicity of Therapeutic Proteins (pages 105–117): Steven J. Swanson
Chapter 5 Preformulation Research: Assessing Protein Solution Behavior during Early Development (pages 119–146): Bernardo Perez?Ramirez, Nicholas Guziewicz and Robert Simler
Chapter 6 Formulation Development of Phase 1–2 Biopharmaceuticals: An Efficient and Timely Approach (pages 147–159): Nicholas W. Warne
Chapter 7 Late?Stage Formulation Development and Characterization of Biopharmaceuticals (pages 161–171): Adeola O. Grillo
Chapter 8 An Empirical Phase Diagram–High?Throughput Screening Approach to the Characterization and Formulation of Biopharmaceuticals (pages 173–205): Sangeeta B. Joshi, Akhilesh Bhambhani, Yuhong Zeng and C. Russell Middaugh
Chapter 9 Fluorescence and Phosphorescence Methods to Probe Protein Structure and Stability in Ice: The Case of Azurin (pages 207–229): Giovanni B. Strambini
Chapter 10 Applications of Sedimentation Velocity Analytical Ultracentrifugation (pages 231–251): Tom Laue
Chapter 11 Field Flow Fractionation with Multiangle Light Scattering for Measuring Particle Size Distributions of Virus?Like Particles (pages 253–268): Joyce A. Sweeney and Christopher Hamm
Chapter 12 Light?Scattering Techniques and their Application to Formulation and Aggregation Concerns (pages 269–305): Michael Larkin and Philip Wyatt
Chapter 13 Effective Approaches to Formulation Development of Biopharmaceuticals (pages 307–328): Rajiv Nayar and Mitra Mosharraf
Chapter 14 Prediction of Aggregation Propensity from Primary Sequence Information (pages 329–347): Mark Cornell Manning, Gabriel J. Evans, Cody M. Van Pelt and Robert W. Payne
Chapter 15 High?Concentration Antibody Formulations (pages 349–381): Steven J. Shire, Jun Liu, Wolfgang Friess, Susanne Jorg and Hanns?Christian Mahler
Chapter 16 Development of Formulations for Therapeutic Monoclonal Antibodies and Fc Fusion Proteins (pages 383–427): Sampathkumar Krishnan, Monica M. Pallitto and Margaret S. Ricci
Chapter 17 Reversible Self?Association of Pharmaceutical Proteins: Characterization and Case Studies (pages 429–455): Vikas K. Sharma, Harminder Bajaj and Devendra S. Kalonia
Chapter 18 Design of a Formulation for Freeze Drying (pages 457–492): Feroz Jameel and Mike J. Pikal
Chapter 19 Protein Conformation and Reactivity in Amorphous Solids (pages 493–506): Lei Zhang, Sandipan Sinha and Elizabeth M. Topp
Chapter 20 The Impact of Buffer on Solid?State Properties and Stability of Freeze?Dried Dosage Forms (pages 507–519): Evgenyi Y. Shalaev and Larry A. Gatlin
Chapter 21 Stabilization of Lyophilized Pharmaceuticals by Control of Molecular Mobility: Impact of Thermal History (pages 521–548): Suman Luthra and Michael J. Pikal
Chapter 22 Structural Analysis of Proteins in Dried Matrices (pages 549–563): Andrea Hawe, Sandipan Sinha, Wolfgang Friess and Wim Jiskoot
Chapter 23 The Impact of Formulation and Drying Processes on the Characteristics and Performance of Biopharmaceutical Powders (pages 565–585): Vu L. Truong and Ahmad M. Abdul?Fattah
Chapter 24 Manufacturing Fundamentals for Biopharmaceuticals (pages 587–604): Maninder Hora
Chapter 25 Protein Stability During Bioprocessing (pages 605–624): Mark Cornell Manning, Gabriel J. Evans and Robert W. Payne
Chapter 26 Freezing and Thawing of Protein Solutions (pages 625–675): Satish K. Singh and Sandeep Nema
Chapter 27 Strategies for Bulk Storage and Shipment of Proteins (pages 677–704): Feroz Jameel, Chakradhar Padala and Theodore W. Randolph
Chapter 28 Drying Process Methods for Biopharmaceutical Products: An Overview (pages 705–738): Ahmad M. Abdul?Fattah and Vu L. Truong
Chapter 29 Spray Drying of Biopharmaceuticals and Vaccines (pages 739–761): Jim Searles and Govindan Mohan
Chapter 30 Development and Optimization of the Freeze?Drying Processes (pages 763–796): Feroz Jameel and Jim Searles
Chapter 31 Considerations for Successful Lyophilization Process Scale?Up, Technology Transfer, and Routine Production (pages 797–826): Samir U. Sane and Chung C. Hsu
Chapter 32 Process Robustness in Freeze Drying of Biopharmaceuticals (pages 827–837): D. Q. Wang, D. MacLean and X. Ma
Chapter 33 Filling Processes and Technologies for Liquid Biopharmaceuticals (pages 839–856): Ananth Sethuraman, Xiaogang Pan, Bhavya Mehta and Vinay Radhakrishnan
Chapter 34 Leachables and Extractables (pages 857–880): Jim Castner, Pedro Benites and Michael Bresnick
Chapter 35 Primary Container and Closure Selection for Biopharmaceuticals (pages 881–896): Olivia Henderson
Chapter 36 Prefilled Syringes for Biopharmaceuticals (pages 897–916): Robert Swift
Chapter 37 Impact of Manufacturing Processes on Drug Product Stability and Quality (pages 917–940): Nitin Rathore, Rahul S. Rajan and Erwin Freund


πŸ“œ SIMILAR VOLUMES


Formulation and Process Development Stra
✍ Feroz Jameel, Susan Hershenson πŸ“‚ Library πŸ“… 2010 🌐 English

A real-world guide to the production and manufacturing of biopharmaceuticalsWhile much has been written about the science of biopharmaceuticals, there is a need for practical, up-to-date information on key issues at all stages of developing and manufacturing commercially viable biopharmaceutical dru

Biopharmaceutical Processing: Developmen
✍ Gunter Jagschies, Eva Lindskog, Karol Lacki, Parrish M. Galliher πŸ“‚ Library πŸ“… 2018 πŸ› Elsevier 🌐 English

<p><i>Biopharmaceutical Processing: Development, Design, and Implementation of Manufacturing Processes</i> covers bioprocessing from cell line development to bulk drug substances. The methods and strategies described are essential learning for every scientist, engineer or manager in the biopharmaceu

Biopharmaceutical Processing: Developmen
✍ Gunter Jagschies, Eva Lindskog, Karol Lacki, Parrish M. Galliher πŸ“‚ Library πŸ“… 2018 πŸ› Elsevier 🌐 English

<p><i>Biopharmaceutical Processing: Development, Design, and Implementation of Manufacturing Processes</i> covers bioprocessing from cell line development to bulk drug substances. The methods and strategies described are essential learning for every scientist, engineer or manager in the biopharmaceu

Strategy for Action – II: Strategy Formu
✍ Giorgio Gandellini, Alberto Pezzi, Daniela Venanzi (auth.) πŸ“‚ Library πŸ“… 2013 πŸ› Springer-Verlag Mailand 🌐 English

<p>The innovative and unique feature of this book is that it does not contain theoretical concept that cannot be translated into practice. This second volume expands the analysis of the strategic decisions, emphasizing the importance of a sustainable competitive advantage, and proposing an integrate

Biopharmaceutical Manufacturing: Princip
✍ Gilleskie G., Rutter C., McCuen B. πŸ“‚ Library πŸ“… 2021 πŸ› Walter de Gruyter 🌐 English

Biopharmaceuticals, medicines made by or from living organisms (including cells from living organisms), are extremely effective in treating a broad range of diseases. Their importance to human health has grown significantly over the years as more biopharmaceutical products have entered the market, a